AKASA vs CodaMetrix (2026)
Two coding platforms with different attitudes to the coder. AKASA runs one engine across coding, documentation integrity and claim work, keeping humans in the loop and covering more of the revenue cycle function. CodaMetrix codes autonomously and says so plainly, spun out of a major academic health system with named deployments at peer institutions and substantiated multi specialty coverage. For a health system standardizing the function on one vendor, AKASA covers more ground. For one whose coding backlog is high volume and standardized, autonomy is where the saving actually is. The numbers to demand differ: a straight through rate against a coding audit for the autonomous system, and a codes removed to codes added ratio for the assistive one, and neither vendor publishes its own.
- One engine spans coding, clinical documentation integrity and the surrounding claim work, which suits a health system standardizing the whole function.
- The longer commercial track record in generative revenue cycle work matters for a function that touches every encounter.
- For an enterprise program, breadth reduces the handoffs where errors and finger pointing accumulate.
- It codes autonomously and is marketed as such, spun out of a major academic health system with named deployments at peer institutions.
- Multi specialty coverage is the explicit differentiator and it is substantiated rather than claimed, with a named attestation behind it.
- For high volume standardized encounters, removing the coder is a different economic proposition from assisting one.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AKASA and CodaMetrix are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | AKASA | CodaMetrix |
|---|---|---|
| Primary category | RCM & Prior Auth AI | Autonomous Medical Coding |
| Founded | Not recorded | 2019 |
| Headquarters | South San Francisco, California | Boston, Massachusetts, United States |
| Website | akasa.com | codametrix.com |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
AKASA
-
Product / capability
AKASA launched an autonomous platform for inpatient medical coding and clinical documentation integrity, building on its AI prebill review products.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
AKASA, formerly Alpha Health, sells generative AI for the provider side of the revenue cycle to hospitals and health systems. Its listed solutions are the Prebill Optimization Suite, which combines Coding Optimizer (missed coding opportunities, quality and compliance risks) and CDI Optimizer (documentation gaps for clinical documentation integrity teams); AI Advisor, a research assistant for revenue cycle staff; Auth Status, which checks pending prior authorization requests on payer portals and records the results; and Claim Status, which does the same for outstanding claims.
Source: AI Health Index, August 2026
CodaMetrix sells autonomous medical coding. Spun out of Mass General Brigham in 2019 from coding AI its founding team built inside that health system in 2016, it offers CMX CARE, a platform that ingests clinical notes (including ambient documentation), registration events, surgical schedules, orders and charges, builds a longitudinal view of each patient's care, and codes and bills facility and professional fee encounters across radiology, pathology, surgery and endoscopy, specialty services and inpatient care.
Source: AI Health Index, August 2026
Questions buyers ask
How are AKASA and CodaMetrix priced and sold?
AKASA sells to hospitals and health systems by solution, each with its own demo request. The platform page describes a dedicated account manager, production reporting, and the option of AKASA's own revenue cycle experts taking over workflows rather than staff using the tools, a service component that will shape the cost.
With CodaMetrix, the commercially important unknown is whether pricing is per chart, per provider, or subscription, which determines whether savings scale with automation rate or are captured by the vendor. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How do AKASA and CodaMetrix handle patient data?
In AKASA's case, the data is complete clinical and financial documentation for whole health systems. Safety engineering, meaning guardrails, hallucination mitigation and how a safety event is handled, is not described.
For CodaMetrix, the solution page says the platform continuously learns, in real time, from coding decisions made by the customer's team and by the coding teams of top performing health systems, and the company's security material says it analyzes denials information shared by customers to improve its models. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Which settings and specialties do AKASA and CodaMetrix cover?
AKASA sells to hospitals and health systems, states a client base of 500 hospitals across all 50 states, and covers coding and documentation integrity before billing, prior authorization status, claim status and a research assistant for revenue cycle staff.
In CodaMetrix's case, the market is United States health systems, from academic centers to smaller organizations. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
What evidence is published for AKASA and CodaMetrix?
For AKASA, the 2024 Authorization Advisor launch claimed up to 50 percent less time on prior authorization and models 38 percent more accurate than GPT-4 at selecting documents, with no test set or method. Cleveland Clinic is deploying the coding and documentation tools, with no results published.
With CodaMetrix, several named academic customers are also investors through their physician organizations, which signals alignment and is also a caveat on independence. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
The comparable differs by design: an autonomous coder should be asked for its straight through rate measured against a coding quality audit with methodology and sample size, while an assistive platform should be asked for its ratio of codes removed to codes added. Neither publishes either. Neither publishes a bias evaluation, and both frame value against internal labor cost rather than against measured accuracy, which is the framing to resist when modeling the return.